Court Rules
All enforcement actions
SettlementMedium Risk

Made-in-China Settles with Connecticut AG Over Bootleg GLP-1 Drug Sales

Made-in-ChinaMay 6, 2026Connecticut Attorney General

Penalty Amount

$300,000

Summary

Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.

Remedy

Made-in-China must prohibit manufacturers from advertising or selling GLP-1s to U.S. customers, deploy a monitoring system to detect and remove such listings, and remove existing GLP-1 listings within five days. The company is subject to a $300,000 penalty, with $30,000 due initially and the remaining $270,000 suspended; additional penalties apply for settlement violations.

Monetary PenaltyInjunctionBanCompliance Program

Contract Impact

In-house legal teams at online trade platforms and e-commerce vendors should review vendor agreements and terms of service to add explicit prohibitions on selling unapproved FDA-regulated drugs, prescription-only medications, and misbranded health products without valid medical oversight. Contracts should include requirements for automated monitoring systems to detect non-compliant listings, specified timeframes for removing prohibited content, and penalty clauses with suspended amounts that trigger upon breach of terms. Platforms should also include indemnification provisions and audit rights to ensure vendor compliance with health and safety regulations.

Contract Search Terms

prohibited product clauseFDA compliancevendor monitoring systemunapproved drug salesprescription requirementlisting removal processsuspended penalty clausemedical oversight requirement

Laws Cited

Connecticut Unfair Trade Practices Act

Violation Types

Entity Details

Entity

Made-in-China

Industry

Other

Official Sources

Source Evidence

Event Date
"05/06/2026"
Entity Name
"Made-in-China"
Fine Amount
"$300,000 penalty to the state, suspended after $30,000"
Laws Cited
"violations of the Connecticut Unfair Trade Practices Act"
Summary
"unlawful sales of bootleg GLP-1 weight loss drugs direct to Connecticut consumers without prescriptions or any medical oversight"
Remedy Types
"prohibits manufacturers from using the platform to advertise or sell GLP-1s to customers in the United States"

Related Enforcement Actions

CT

National Highway Traffic Safety Administration

Connecticut Attorney General William Tong joined a coalition of states and local governments in filing suit against NHTSA over its rule weakening fuel economy standards for new passenger cars and light trucks. The lawsuit alleges the rule violates the agency’s statutory mandate and the Administrative Procedure Act; no penalty or final remedy is reported.

CT

U.S. Environmental Protection Agency

Connecticut Attorney General William Tong joined a multistate coalition suing the EPA over its repeal of greenhouse gas pollution limits for power plants and separately filed a notice of intent to sue over regulation of existing gas plants. The coalition asks the court to overturn the repeal and restore the protections; the release reports no monetary penalty or final order.

CT

Sandoz Inc. and Fougera Pharmaceuticals Inc.

$400.0M

Connecticut Attorney General William Tong announced a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving allegations that the generic drug manufacturers conspired to inflate prices, limit competition, and restrain trade. The settlement includes consumer restitution and injunctive reforms; court approval was being sought.

CT

U.S. Department of Homeland Security

Connecticut Attorney General William Tong joined a coalition of 21 attorneys general in submitting a comment letter opposing a DHS rule that allows certain affirmative asylum applications to be referred to removal proceedings without an asylum officer interview. The coalition argues the rule violates federal law and harms asylum seekers, including unaccompanied children; this was a policy opposition letter, not a privacy enforcement action.

CT

NextEra Energy and Dominion Energy

Connecticut and Massachusetts co-led a coalition protest urging FERC to reject the proposed NextEra Energy-Dominion Energy merger. The coalition argued that the merger could increase market power and threaten energy affordability, reliability, and competition; the release does not report a final enforcement decision or penalty.

CT

Unspecified home improvement contractors

Connecticut officials warned residents about potential home improvement scams before an approaching nor’easter, including unlicensed contractors, high-pressure sales tactics, and demands for full payment upfront. The release provides consumer guidance on checking contractors and contract requirements; it does not announce an enforcement action or penalty against a named entity.